Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2008

Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118(6):2111-20.

Arora N, Turbendian HK, Scognamiglio T, Wagner PL, Goldsmith SJ, Zarnegar R, et al. Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery. 2008;144(6):942-7; discussion 947-8.

Benedettini E, Nguyen P, Loda M. The pathogenesis of prostate cancer: from molecular to metabolic alterations. Diagn Histopathol (Oxf). 2008;14(5):195-201.

Savalia D, Westblade LF, Goel M, Florens L, Kemp P, Akulenko N, et al. Genomic and proteomic analysis of phiEco32, a novel Escherichia coli bacteriophage. J Mol Biol. 2008;377(3):774-89.

Ali S, Nassar A, Siddiqui MT. Crush preparations of meningiomas: can grading be accomplished? Diagn Cytopathol. 2008;36(11):827-31.

Bucci M, Roviezzo F, Brancaleone V, Di Lorenzo A, Evangelista S, Gori M, et al. ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice. Vascul Pharmacol. 2008;49(2-3):84-90.

Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature. 2008;455(7212):547-51.

Tewari A, Rao S, Martinez-Salamanca JI, Leung R, Ramanathan R, Mandhani A, et al. Cancer control and the preservation of neurovascular tissue: how to meet competing goals during robotic radical prostatectomy. BJU Int. 2008;101(8):1013-8.

Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation. 2008;118(15):1577-84.

Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2008;68(4):618-34.